Cargando...
Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product
BACKGROUND: Botulism is a rare, serious, and sometimes fatal paralytic illness caused by exposure to neurotoxins produced by Clostridium botulinum bacteria. Patients with documented or suspected exposure to botulinum toxin serotypes A-G can be treated with BAT(®) [Botulism Antitoxin Heptavalent (A,...
Gardado en:
| Publicado en: | PLoS One |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Public Library of Science
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6837762/ https://ncbi.nlm.nih.gov/pubmed/31697731 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0224700 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|